News Business Sports Entertainment Life Obituaries Opinion
Jobs Homes Cars Classifieds Shopping
Local Bloggers Cheap Tech Eco-Confessions Faceoff Furst Draft Heard on the Street Med City Movie Guy Pulse on Health Political Party

Search PB Blogs

Loading

Categories

309 posts categorized "Downtown Roch. buzz"

July 23, 2015

Quiet period to end for Celyad (former Cardio3) on July 29

Here's an interesting update from a site called Marketbeat.com about the former Cardio3, now trading in U.S. as Celyad. This Belgium firm has deep ties to Mayo Clinic and will soon occupy an entire floor of the Minnesota Biobusiness Center in downtown Rochester.

 Celyad SA’s  quiet period is set to expire on Wednesday, July 29th. Celyad SA had issued 1,460,000 shares in its initial public offering on June 19th, Market Beat reports.

CelyadThe total size of the offering was $100,097,600 based on an initial share price of $68.56. During Celyad SA’s quiet period, insiders and underwriters involved in the IPO are restricted from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the expiration of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

 

CYAD has been the subject of a number of recent recent research reports. Analysts at Piper Jaffray initiated coverage on shares of Celyad SA in a research note on Tuesday, July 14th. They set an “overweight” rating and a $95.00 price target on the stock. Separately, analysts at Maxim Group reiterated a “buy” rating on shares of Celyad SA in a research note on Sunday, June 21st.

Celyad SA remained flat at $60.44 during during mid-day trading trading on Wednesday. 126 shares of the company’s stock traded hands. Celyad SA has a one year low of $47.52 and a one year high of $67.94. The stock’s 50-day moving average is $54.65 and its 200-day moving average is $54.65.

 

July 22, 2015

Holiday Inn: Roch.'s downtown hotel to close at end of August

Don't expect to book a room in Rochester's downtown Holiday Inn after Aug 31, according to the hotel chain's national reservation line.

Holiday-inn-rochester-3336465069-4x3An InterContinental Hotels representative on the reservation line said this week that Rochester employees said the 170-room hotel at 220 Broadway Ave. S will close at the end of August. They told the ICH representative the closing is because of the sale of the hotel.

For several months, word has been leaking out about a deal to sell the downtown hotel to an unnamed buyer who is planning to convert the 46-year-old hotel into a senior living facility.

If the buzz is correct, these talks have been going on for quite a while without reaching closure. Now the employees are saying a closure is on the way.

At least for the hotel, if not the real estate deal. 

July 17, 2015

Downtown tower's construction waiting on financing

Construction on a 23-story downtown Rochester tower has yet to begin because the developer has not finalized financing for the project, according to a city official.

In May, the City of Rochester pledged $6.5 million in assistance to developer Gus Chafoulias to build his long-planned $140 million Broadway at Center tower. Chafoulias, with limited assistance from his son Andrew Chafoulias and Titan Development and Investments, has been working on different versions of this project since 2007.

TowerBroadway at Center will house a 264-room Hilton Hotel, 33 apartment units and space for office, retail and restaurant use. More than $14 million — including the city's $6.5 million assistance to the developer and the remainder of infrastructure costs — is planned to be reported as Destination Medical Center local contributions and credited toward the city's $128 million commitment.

The tower is to be built on South Broadway and East Center Street, just north of Broadway Residence and Suites by BridgeStreet. Since early last year, buildings that previously housed CJ's Midtown Lounge, Ginny's Fine Fabrics and Jakobson Management Co. have sat empty on the site. When the tenants were asked to vacate, Titan officials estimated that the buildings would be demolished during the summer of 2014.

When approving the project, the city agreed to work in conjunction with the developers to build an attached public parking ramp. But city officials said they have to wait on final paperwork from Titan Development before construction can start.

"Chafoulias indicated a while back that they are still reviewing some of their financing options for the project, so they have not provided us with that signed development agreement as of yet. I'm anticipating it should be fairly soon," City Redevelopment Director Terry Spaeth said. "I know they are looking at a couple different financing options."

The development agreement includes a number of provisions about vacating an alley, conveying properties and approving easements.

Spaeth said it's estimated it will take 22 months, from start to finish, to build Broadway at Center. The city's portion of the project is expected to take nine to 12 months to complete. The plan is for the city work to be completed to coincide with the opening of the overall project.

"Once they get going, I suspect things will get moving pretty rapidly," he said. "The first step is to get the development assistance agreement signed."

When asked about the status of the Broadway at Center project, Titan Marketing and Communications Manager Sheila Thoma said there wasn't much to report.

"I do not have a new/significant update. The project is still on course. With a major project like this, there are a lot of moving parts and it takes time to solidify all details," she wrote in response to inquiries about when the CJ's and Ginny's Fine Fabrics buildings would be demolished.

On May 4, the city approved a development assistance agreement with Titan about Broadway at Center. The Rochester Economic Development Authority, a board comprised of the seven Rochester City Council members, approved $6.5 million in tax increment financing and land write-downs. The EDA had put its development assistance agreement on hold until the Destination Medical Center Corp. board of directors named Broadway at Center as a DMC project. That happened on April 30.

Broadway at Center is reminiscent of a previous project called Time Square that Gus Chafoulias proposed for that block 15 years ago. When Mayo Clinic opted not to lease office space in the $200 million project, Chafoulias withdrew it in 2000.

"This is the single biggest disappointment of my career," Chafoulias said after making the announcement. "It never feels good when you fail. It didn't work out, but it's not the end of the world."

After Chafoulias withdrew, Dubai-based investors stepped in and built a 26-story tower, the tallest building in Rochester, on that corner. That tower, now known as Broadway Residence and Suites, stands next door to the proposed Broadway at Center project.

 

July 14, 2015

Piper Jaffrey gives Celyad (former Cardio3) stock positive rating

Here's an interesting item that floated into my email box this a.m. about the former Cardio3, now trading in U.S. as Celyad. This Belgium firm has deep ties to Mayo Clinic and will soon occupy an entire floor of the Minnesota Biobusiness Center in downtown Rochester.

By the way, a rating of "overweight" is a good thing. It means the stock is a better value that other stocks in the same sector.

Here's the item as posted by Piper Jaffray:

Piper Jaffray initiates coverage on Celyad SA with a Overweight rating and a price target of $95.00.

Analyst Edward Tenthoff commented, "Celyad is a leading cell therapy company. CelyadCelyad is conducting the Phase III CHART-1 trial of autologous cell therapy C-CURE in heart failure patients with data likely next summer. The company will initiate the CHART-2 trial this year with data in 2017. Celyad recently in-licensed novel CAR-T technology for cancer currently in a Phase I AML and multiple myeloma study. Celyad is listed on the EuroNext exchange in Brussels and Paris, and just completed a U.S. IPO issuing 1.46 million shares at US$68.56 raising gross proceed of US$101 million. CYAD shares have sold off since the IPO providing an attractive entry point at US$54.71, in our view. We are initiating coverage with an Overweight rating and US$95 price target."

Shares of Celyad SA closed at $54.71 yesterday.

 

 

June 26, 2015

A taste of the East Coast coming to Med City

The flavor of the East Coast is on its way to southwest Rochester.

Joe Phillips is cooking up a new eatery called Jersey Jo's to serve up "authentic Philly Cheesesteaks and more."

FireShot Capture - Order Online - http___jerseyjos.com_order-onlineHe hopes to be able to open Jersey Jo's by mid-July at 187 16th Ave. SW. Cousins Subs is moving out of that 1,600-square-foot spot in the Shoppes on Second commercial center at the end of June. That address will put him just a couple blocks away from Mayo Clinic's St. Marys Hospital and many hotels.

Phillips, a software programmer who will continue that profession remotely from the restaurant, said this new project started very simply.

"I couldn't get a cheesesteak anywhere around here that I liked," he said. So after years of looking, he finally decided to open a place of his own.

Phillips plans to "import" many of the ingredients for the Jersey Jo's signature cheesesteak sandwiches from the East Coast to create as authentic of a flavor as possible.

In addition to Philly cheesesteaks, Jersey Jo's also will serve cold hoagie sandwiches, chicken wings and a trio of specialty burgers. The meat will be sliced on-site, deli-style for each of the made-to-order sandwiches.

While he has long worked in the technology industry, Phillips knows his way around a kitchen from years in restaurants during college.

Phillips' vision for Jersey Jo's is to create a laid-back place like the small mom-and-pop corner shops he remembers from growing up in New Jersey.

"I want to offer a nondiscriminatory place for people to come and feel welcome while they have some good food," he said.

He expects to have about eight people on staff.

 

June 15, 2015

Former Cardio3 launching $99 million IPO in US and worldwide

Celyad, formerly Cardio3 Biosciences, announced the terms for its $99 million stock offering this morning.

The Belgium-based Celyad, which is building a manufacturing facility in downtown Rochester and has close ties with Mayo Clinic, hopes to raise $99 million by offering 1.4 million shares at $70.98 per share.

CelyadWhile Celyad has traded on the European stock markets of NYSE Euronext Brussels and NYSE Euronext Paris for some time, this stock offering would introduce the regenerative medicine firm directly to the U.S. market. It has applied to make the U.S. offering on the Nasdaq stock market under the symbol CYAD.

A registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. It cannot sell or accept offers to buy until the SEC OKs the registration.

This move could benefit Mayo Clinic, which owned 2.69 percent of Celyad as of March 3. Mayo Clinic first acquired equity in Cardio3 in 2007, when it licensed stem-cell research by Mayo Clinic's Dr. Andre Terzic and Dr. Atta Behfar. Its cardiopoiesis technology repairs patients' hearts by re-programming their own stem cells to regenerate cardiac tissue.

Earlier this year, the Rochester City Council recently approved a lease for Celyad to take over the entire fifth floor of Rochester's Minnesota BioBusiness Center. Rochester Area Economic Development Inc. and the Minnesota Department of Employment and Economic Development also are involved in the deal.

Celyad is building a prototype manufacturing facility in the 14,963-square-feet of space on the fifth floor of the downtown building. Mayo, which leases the fourth through eighth floors, moved its employees out of the fifth floor earlier this year. The five-year lease calls for it to pay a rent of $18 per square foot, or $22,444.50, per month. The city agreed in the lease to pay for $600,000 in equipment and improvements to the space.

DEED is offering Ceylad a $357,000 Minnesota Job Creation Fund award if it invests $1.5 million in Rochester within a year and hires 33 employees within two years. The average wages of the new jobs will be $21.52 per hour.

June 10, 2015

Conley-Maass building sold for $450,000

The anticipated sale of a 115-year-old downtown Rochester landmark wrapped up on June 1.

Hunter and Traci Downs bought the Conley-Maass building at 14 Fourth St. SW for $450,000 with the intention of restoring it and using it as a business center. The couple, under the corporate name of CMD Holdings LLC, purchased it from AC Acquisitions LLC of Rochester
09062015conleymaasbuilding
AC Acquisitions, an offshoot of the Chafoulias family's Titan Development & Investments company, bought the building for $400,000 in 2013.

The building's last two tenants, Words Players Theatre and the Just For Kix dance studio, are moving out and construction is expected to begin soon.

June 09, 2015

Roch. repair shop get new name, but everything else remains same

The name over the door at Rochester's 434 South Broadway is new, but everything else about the auto repair shop is the same as it was before.

The Eastman Auto Repair sign recently went up on the small shop along the Zumbro River, though customers of Zeus Auto Repair will find nothing unchanged, said Zane Zodrow.

06092015eastmanautoZodrow, who owned Zeus Auto, says he sold the business to Gay Eastman at the start of 2015. The new sign just reflects that sale. He remains the manager of the three person, full-service shop.

"It's all the same. Honesty is still our main thing. We still treat people how we would want to be treated," he said. "We offer the same warranties."

However, Zodrow does a see a change coming down the road in the future.

The shop's building, which is owned by local investors, stands where Associated Bank would like to build a branch. That proposed project is still scheduled to go before the Rochester City Council after being rejected by the Rochester-Olmsted Planning and Zoning Commission.

Whether the bank branch goes forward or not, Zodrow does anticipate that the current shop will be  eventually be displaced by some sort development.

"We are looking for a new location," he said.

Zeus Auto Repair has operated at the prominent South Broadway location since 2010, when Zodrow moved from his previous spot on on Second Street Southwest.

May 28, 2015

Mayo hires consultant to map out Discovery Square

To help fire up Discovery Square as "a catalyst" to create jobs in downtown Rochester, Mayo Clinic has contracted a feasibility study, independent of the Destination Medical Center Corp.

Mayo Clinic has hired the DMC development manager, Hammes Co. of Madison, Wis., to analyze the Discovery Square piece of the DMC vision and offer a market plan of how DiscoverySquarethe medical and technology research area might be developed. Mayo is paying Hammes $1.5 million to conduct the study, which is expected to be completed by the end of the year.

One expected tenant is Epic, a Madison-based software system that recently signed a contract to help build an electronic health record system for Mayo Clinic. It's planning on having many employees based in Rochester.

"They've indicated a strong interest in the Discovery Square concept, and we're exploring ways they may participate in that," said Bolton.

Discovery Square is described as "the focal point" for Mayo Clinic's expansion of its science and technology institutes, and it's designed as a place for private companies and others to work with Mayo on research and other projects. It's marked on the DMC map as being central to the Gonda Building and the Mayo Medical School.

"The Square is designed to be playful and artful, similar to the Google Commons in order to, quite simply, attract the best and the brightest, the most creative minds in the world," according to the DMC plan.

Mayo Clinic owns about 35 percent of the property within the proposed Discovery Square area.

The goal of the new study is to map out the area more specifically and identify potential partners and funding streams to make it sustainable.

Jeff Bolton, Mayo's chief administrative officer and the chair of DMC's Economic Development Agency, said Mayo funded the study because it's not part of the DMC EDA's scope.

"The EDA budget is really to provide staffing to support the DMCC board, to work with developers and help market the DMC concept," he said. "Mayo Clinic views this as area where we could serve as an important catalyst to advance the DMC vision. That's why we stepped up and are making this investment."

Mayo Clinic's relationship with Hammes dates back to the very early days of the DMC concept in 2008 before it became public. Mayo Clinic first officially contracted with the company about DMC in 2011. When the EDA signed its own contract with Hammes last year for $2.3 million a year, it had no ongoing Mayo contracts.

Bob Dunn, president of Hammes, explained that this study will be similar to his company's work on the overall DMC plan but will be much more detailed.

This study will include a master plan, a conceptual design, preliminary engineering, financial analysis, financing plan, a market analysis, a review of effective land use and operational aspects for Discovery Square.

"This will be a block-by-block plan," he said. "But we're not starting at ground zero. Mayo, which owns a good portion of the land in Discovery Square, has already thought a lot about this development."

Meanwhile, Mayo is actively working with companies to try to get them to locate there, Bolton said.

"We're out marketing the concept," said Mayo's Bolton. "Obviously, we have an interest in terms of attracting groups to collaborate with us."

The project's success likely will be driven by what partners want to work with Mayo Clinic.

"If I were to forecast, I'd say there will be multiple of owners of facilities in Discovery Square. Many will probably be owned by private developers," predicted Bolton. "There won't be a monolithic owner of the facilities. The free market will play out in this environment."

He added that Mayo Clinic may participate "directly or indirectly" in some of the development.

The multimillion dollar question is when actual development of this new job generator area will begin.

"We'll need a critical mass of corporate engagement in order to have a developer to put that first shovel in the ground," said Bolton.

Dunn said this is a fascinating feature of what is already a unique project.

"DMC and Discovery Square, to me, is one of the most interesting things that I can think of nationally in terms of major economic development," he said. "It's unique because impact Mayo Clinic can bring to something like this in a market that's now beginning to mature and evolve very quickly."

May 22, 2015

Boutique owner to open second Rochester shop

A new boutique is bringing its quirky style to downtown Rochester this summer.

Camy Couture is slated to open on June 4 at 112 First Ave. SW, says owner Kim Shea. That's the high-profile spot next to O&B Shoes that previously housed Trademark Uniforms Inc. and About Face prior to that.

Darci Fenske of Paramark Real Estate brokered the deal.

CamycouturedowntownShea opened her first Camy Couture in Rochester's Shoppes of Maine area in 2013. She describes the store as having funky and unique women's fashions for "trendy moms and everybody else" at a reasonable price. It also carries accessories like handbags, scarves and sunglasses.

"We specialize in buying small sets. Once they are gone, they are gone. You don't see everyone around town wearing what you just bought," she said.

Now Shea is launching a second shop in the heart of Rochester's downtown.

"The opportunity came out of absolutely nowhere. It was too hard to pass up this location," she said. "The exposure of being downtown will help both stores."

She assures that new store will have the same "feel" of her at 4270 Maine Ave. S.E. Shea plans to have two on staff downtown. The Shoppes on Maine store is staffed by three, including her.